Oglobe GM 1mg/500mg/0.2mg Tablet SR
Marketer
Cian Health Care Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Oglobe GM 1mg/500mg/0.2mg Tablet SR
Diabex Trio 1mg/500mg/0.2mg extended-release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose levels. Diabex Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to hyperglycemia, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan, requiring adherence to a healthy diet, regular exercise, and weight management as recommended by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Prompt recognition and treatment are vital; maintain regular mealtimes and carry readily available glucose sources (e.g., sugary snacks or juice). Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician prior to commencing treatment. Pregnant or breastfeeding women require medical consultation before use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function as directed by your doctor.
Primary Ingredients of Oglobe GM 1mg/500mg/0.2mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Oglobe GM 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Oglobe GM 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Oglobe GM 1mg/500mg/0.2mg Sustained-Release tablet should be taken on an empty stomach.
Common Side effects of Oglobe GM 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Oglobe GM 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Oglobe GM 1mg/500mg/0.2mg Extended-Release Tablets should be taken on an empty stomach.
How Oglobe GM 1mg/500mg/0.2mg Tablet SR works:
Each Oglobe GM SR tablet (1mg/500mg/0.2mg) contains a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Oglobe GM 1mg/500mg/0.2mg SR tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
The extended-release Oglobe GM 1mg/500mg/0.2mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Oglobe GM tablets (1mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer via breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Oglobe GM 1mg/500mg/0.2mg Tablet SR, as its use may be unsafe. This medication is not advised for those with severe kidney impairment; physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Oglobe GM 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Medical advice is essential. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in cases of severe liver dysfunction.
What if you forget to take Oglobe GM 1mg/500mg/0.2mg Tablet SR :
Should you forget to take a dose of Oglobe GM 1mg/500mg/0.2mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Oglobe GM 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently